Camillo, Heirsey D.
HRN: 20-88-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2023
CEFUROXIME 500MG (TAB)
09/22/2023
09/29/2023
PO
500mg Tab
BID
S/P NSVD W/ RMLE; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes